Evolution of Cerebral Ischemia Assessed by Amide Proton Transfer-Weighted MRI by Guodong Song et al.
March 2017 | Volume 8 | Article 671
Original research
published: 02 March 2017
doi: 10.3389/fneur.2017.00067
Frontiers in Neurology | www.frontiersin.org
Edited by: 
Thanh G. Phan, 
Monash Health, Australia
Reviewed by: 
Parnesh Raniga, 
Monash University, Australia 
Götz Thomalla, 
University Medical Center Hamburg-
Eppendorf, Germany
*Correspondence:
Min Chen  
chenmin62@yahoo.com
Specialty section: 
This article was submitted to Stroke, 
a section of the journal 
Frontiers in Neurology
Received: 13 November 2016
Accepted: 15 February 2017
Published: 02 March 2017
Citation: 
Song G, Li C, Luo X, Zhao X, 
Zhang S, Zhang Y, Jiang S, Wang X, 
Chen Y, Chen H, Gong T, Zhou J and 
Chen M (2017) Evolution of Cerebral 
Ischemia Assessed by Amide Proton 
Transfer-Weighted MRI. 
Front. Neurol. 8:67. 
doi: 10.3389/fneur.2017.00067
evolution of cerebral ischemia 
assessed by amide Proton  
Transfer-Weighted Mri
Guodong Song1,2, Chunmei Li1, Xiaojie Luo1, Xuna Zhao3, Shuai Zhang1,2, Yi Zhang3, 
Shanshan Jiang3, Xianlong Wang4, Yuhui Chen5, Haibo Chen5, Tao Gong5, Jinyuan Zhou3 
and Min Chen1,2*
1 Department of Radiology, Beijing Hospital, National Center of Gerontology, Beijing, China, 2 Graduate School of Peking 
Union Medical College, Beijing, China, 3 Department of Radiology, Johns Hopkins University, Baltimore, MD, USA, 
4 Department of Radiology, Zhujiang Hospital of Southern Medical University, Guangzhou, China, 5 Department of Neurology, 
Beijing Hospital, National Center of Gerontology, Beijing, China
Amide proton transfer-weighted (APTW) magnetic resonance imaging (MRI) has recently 
become a potentially important tool for evaluating acidosis in ischemic stroke. The 
purpose of this study was to evaluate the dynamic pH-related changes in the lesions 
in patients with ischemia. Thirty-nine patients with ischemic stroke (symptom onset to 
imaging time ranging 2 h–7 days) were examined with a 3.0-T MRI system. Patients were 
divided into four groups: at the hyperacute stage (onset time ≤ 6 h), at the acute stage 
(6 h < onset time ≤ 48 h), at the early subacute stage (48 h < onset time ≤ 96 h), and at 
the late subacute stage (96 h < onset time ≤ 168 h). The APTW signal intensities were 
quantitatively measured in multiple ischemic regions for each patient. Compared with 
the contralateral normal white matter, APTW signals were significantly lower in ischemic 
tissue for all four stages (P < 0.05). The APTW signal intensities (APTWave and APTWmin) 
increased consistently with onset time (R2 = 0.11, P = 0.040; R2 = 0.13, P = 0.022, 
respectively). APTWmax–min showed a continued reduction with onset time (R2 =  0.44, 
P <  0.001). Our results suggest that persistent tissue acidification could occur after 
ischemia, and as the time from stroke onset increases, the acidotic environment would 
alleviate. APTW signal intensities could reflect pH-weighted properties in ischemic tissue 
at different stages and time points.
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inTrODUcTiOn
In the ischemic brain, tissue dysfunction develops from a complex cascade of pathophysiological 
events that progress temporally and spatially (1, 2). After the critical reduction of cerebral blood flow, 
normal cerebral oxygen and glucose metabolism are destroyed, and accumulated lactate concentra-
tions due to anaerobic glycolysis often incur intracellular acidosis (3). The maintenance of appropri-
ate intracellular pH in the brain is of paramount importance to its normal physiological activities, 
for pH regulates various cellular activities and processes (4, 5). As glial acidification is the key trigger 
of excess glutamate liberation, the glutamate-mediated excitotoxicity can directly induce neuronal 
cell death (6). Without timely restoration of blood flow, tissue acidification can lead to irreversible 
2Song et al. APTW MRI of Cerebral Ischemia
Frontiers in Neurology | www.frontiersin.org March 2017 | Volume 8 | Article 67
tissue damage (7). Intracellular pH of brain tissue varies over 
ischemic time and cerebral energy status after stroke (8). Thus, 
tissue pH may serve as a potential surrogate biomarker to reflect 
the metabolic state and disease evolution during ischemia (9).
Although the use of multimodal magnetic resonance imag-
ing (MRI) protocols in the detection and evaluation of ischemic 
stroke is increasing (10–12), routine MRI techniques such as 
perfusion-weighted imaging (PWI) and diffusion-weighted 
imaging (DWI) are insufficient to depict tissue pH changes, except 
the magnetic resonance spectroscopy (MRS) method. MRS can 
detect the changes of cerebral metabolites and measure tissue pH 
non-invasively, and previous MRS studies have found that early 
acidosis and subacute alkalosis occurred during ischemic stroke 
(13, 14). Nevertheless, there still remain challenges for the MRS 
approach due to low spatial and temporal resolution which limit 
its clinical application in brain ischemia (15). Thus, novel pH-
weighted imaging methods are desired to evaluate the change of 
intracerebral pH after stroke.
As a variant of the chemical exchange saturation transfer 
(CEST) MR imaging method (16), amide proton transfer-
weighted (APTW) MRI is a novel protein and peptide-based 
imaging technique (17). By detecting endogenous concentrations 
of exchangeable amide protons in  vivo, APTW MRI has been 
employed to evaluate the changes of mobile abnormal proteins 
and peptides in tumors (18, 19) and other diseases (20). Besides, 
it has shown considerable promise in detecting the change in pH 
non-invasively without any exogenous contrast agents. APTW 
MRI can assess the severity of tissue acidification and depict 
the ischemic penumbra by complementing with traditional 
MRI methods in hyperacute and acute stroke (9, 21–25). To 
our knowledge, APT-related studies have paid little attention to 
evaluating dynamic changes of pH in cerebral infarction (26), 
especially in patients. The clarification of detailed environmental 
evolutions of the ischemic tissue by APTW MRI would promote 
our understanding of stroke pathophysiology and may benefit 
future APT studies in stroke. In this study, changes of tissue pH 
environment in ischemic stroke are explored using the APTW 
MRI technique. We will systematically describe APTW MRI 
signal characteristics in stroke at different phases and investigate 
their dynamic changes with time, which may facilitate under-
standing the evolution of ischemic tissue.
PaTienTs anD MeThODs
Patients
The study was approved by the local institutional review board. 
Written informed consent was obtained from all patients partici-
pating in this study. Ischemic stroke patients were prospectively 
and consecutively enrolled during March 2014 to April 2016. 
The diagnosis of ischemic stroke was based on clinical findings 
and computed tomography or MRI scans (27). Exclusion criteria 
included patient’s age <18  years, receiving intravenous t-PA 
therapy and endovascular thrombectomy before APTW MRI, 
other brain disorders, unclear symptom onset time, insufficient 
image quality, small lesions (less than 10 mm in diameter on the 
transverse DWI), and contraindications to MRI.
Patient groups
The time intervals to describe different phases of stroke have not 
reached general agreement among various researchers (28–30). 
In our study, 39 patients enrolled were divided into four groups 
based on the symptom onset to imaging time (28): 4 patients 
at the hyperacute stage (onset time ≤  6  h), 18 patients at the 
acute  stage  (6 h <  onset time ≤  48 h), 10 patients at the early 
subacute stage (48 h < onset time ≤ 96 h), and 7 patients at the 
late subacute stage (96 h < onset time ≤ 168 h).
Mri imaging Techniques
Magnetic resonance imaging images were acquired on a 3.0-T MRI 
system (Achieva, Philips Medical Systems, Best, the Netherlands) 
with an 8-channel receive-only head coil. Several routine MR 
images, including axial Diffusion-weighted (DW), T2-weighted, and 
T1-weighted were collected to confirm the locations of the ischemic 
stroke lesions and exclude any other structural abnormalities.
Amide proton transfer-weighted MRI was acquired with 
a fat-suppressed, single-shot, turbo-spin-echo sequence, and 
the parameters were as follows: repetition time  =  3,000  ms, 
turbo-spin-echo factor factor  =  54, acquisition matrix 
size = 104 × 101, reconstruction matrix size = 400 × 400, field 
of view = 230 mm × 221 mm, and slice thickness = 6 mm. A 
multi-offset, multi-acquisition APTW protocol (31, 32) was used, 
and 31 offsets spanned +6 to −6 ppm [31 offsets = 0, ±0.25, ±0.5, 
±0.75, ±1, ±1.5, ±2, ±2.5, ±3.0 (2), ±3.25 (4), ±3.5 (8), ±3.75 (4), 
±4 (2), ±4.5, ±5.0, ±6.0 ppm; the values in parentheses were the 
number of acquisitions, which was 1 if not specified]. An unsatu-
rated image was also acquired for signal normalization. One 
transverse slice was acquired with the largest ischemic lesions, 
matching the DWI location. Besides, to evaluate the conventional 
magnetization transfer effect, a saturated image at 15.6 ppm was 
also acquired. The total duration of the APTW MRI sequence 
was 3 min 12 s.
Data Processing and analysis
We used the Interactive Data Language (Exelis Visual Information 
Solutions, Boulder, CO, USA) to process the APTW MRI data. 
The pH-sensitive CEST effect was detected by analyzing the 
z-spectrum on a pixel-by-pixel basis (17). In the z-spectrum, 
the amide proton frequency was conventionally referenced with 
respect to the water signal (assigned to be 0 ppm). Magnetization 
transfer ratio was defined as MTR =  1 −  Ssat/S0 (in which Ssat 
and S0 were the signal intensities with and without selective 
RF irradiation), and MTR asymmetry (MTRasym) analysis was 
performed with respect to the water signal. Thus, the APTW 
signal was calculated based on the MTRasym at 3.5  ppm, i.e., 
MTRasym(3.5  ppm) =  Ssat(−3.5  ppm)/S0 −  Ssat(+3.5  ppm)/S0. Of 
course, MTRasym(3.5  ppm) contains not only the mobile amide 
proton transfer ratio (APTR), which is related to pH and other 
changes in tissue, but also the complicating MTR ppmasym
’ ( . )3 5 , 
resulting in MTR (3.5 ppm) = APTR + MTR ppmasym asym
’ ( . )3 5 . 
MTR ppmasym
’ ( . )3 5  can be attributed to the upfield nuclear 
Overhauser enhancement (NOE) effect of various non-
exchangeable protons (33, 34). Thus, MTRasym(3.5 ppm) images 
are generally called APTW images.
FigUre 1 | examples of the definition of the regions of interest (rOis). Five ROIs in the ischemic tissue and one ROI in the contralateral normal white matter 
were chosen.
Table 1 | baseline demographic data for patients with different stages.
Variable hyperacute stage (0–6 h) acute stage (6–48 h) early subacute stage (48–96 h) late subacute stage (96–168 h) P value
Age (years)a 63 ± 6 66 ± 4 58 ± 4 61 ± 2 0.587
Male/female 2/2 10/8 6/4 5/2 0.769
Onset time (h)a 4.5 ± 1.0 31.5 ± 2.9 79.2 ± 3.7 147.4 ± 6.3 <0.001
aMean value ± SE.
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The quantitative MRI analysis was performed in five small 
regions of interest (ROIs) within the ischemic lesions defined by 
DWI for each patient (Figure 1). One ROI in the contralateral 
normal white matter (CNWM) was also chosen for com-
parison. The maximum APTW (APTWmax) signal intensity, the 
minimum APTW (APTWmin) signal intensity, and the difference 
between APTWmax and APTWmin (APTWmax–min), which reflects 
APTW signal heterogeneity, the average APTW (APTWave), 
and MTR(15.6  ppm) signal intensity (corresponding to the 
APTWmin), were reported. In the contralateral normal tissue, 
APTW (APTW@CNWM) and MTR(15.6 ppm) signal intensities 
were also calculated.
statistical analysis
All statistical analyses were performed using the SPSS 17.0 soft-
ware package. APTW and MTR signal intensities in the ischemic 
tissue and the contralateral normal tissue were obtained for each 
patient. The results were presented as the format of mean ± SE. 
The difference of sex among the four groups was compared using 
Chi-squared test. Time-related changes of APTW signals were 
assessed by regression analysis, and goodness-of-fit was deter-
mined by calculation of an R2 value. One-way analysis of variance 
with post hoc tests was performed for comparing multiple values 
of parameters at different stages. Tukey’s post hoc tests were used 
if the P value resulted from tests for homogeneity of variance 
was greater than or equal to 0.05. Otherwise, Games-Howell 
post hoc tests would be employed if P < 0.05. The comparisons 
of MTR parameters between the ischemic tissue and CNWM 
were analyzed by Student’s t-test. P values <0.05 were considered 
statistically significant.
resUlTs
baseline Data
A total of 62 patients were recruited and 39 patients remained 
in our study. Twenty-three patients were ineligible because 
of small ischemic lesions on the routine DW images (n =  10), 
accompaniment with brain tumors (n = 2), an unclear onset time 
(n = 4), obvious motion artifacts (n = 5), and the intravenous 
t-PA treatment before APTW MRI (n = 2). Of the 39 included 
patients, baseline data are shown in Table  1. These data show 
no significant sex or age-related differences, while there were 
obviously significant differences of the mean onset to scan time 
among four stages.
MTrasym spectrum and aPTW image 
Features
Figure  2 shows the average MTRasym spectra corresponding to 
APTWmin values of the four stages. For all patients enrolled, the 
CEST effect in the ischemic tissue showed a visible reduction at 
the offset range of 2–5 ppm in the MTRasym spectra compared with 
the CNWM. All MTRasym spectra became negative at offsets greater 
than 3 ppm (in the ischemic areas) or >3.5 ppm (in the CNWM), 
as reported previously (35, 36). The maximal CEST effect reduc-
tion appeared at the offset of 3.5 ppm, where amide resonances of 
the backbones of soluble proteins and peptides were present, and 
FigUre 2 | Measured MTrasym spectra in the ischemic tissue and the contralateral normal white matter (cnWM) of different stages (corresponding 
to the aPTWmin value). (a) Hyperacute stage. (b) Acute stage. (c) Early subacute stage. (D) Late subacute stage. (e) The combination of MTRasym spectra in the 
ischemic tissue of different stages. (F) The combination of MTRasym spectra in the CNWM of different stages. The chemical exchange saturation transfer effect 
reduced in the offset range of 2–5 ppm in all stages. MTRasym(3.5 ppm) showed the largest reduction in the hyperacute stage (a). An increase was shown in the 
MTRasym(3.5 ppm) in the ischemic tissue (e).
4
Song et al. APTW MRI of Cerebral Ischemia
Frontiers in Neurology | www.frontiersin.org March 2017 | Volume 8 | Article 67
the process has been proved to be sensitive to the change of pH 
(17). Among different stages, MTRasym(3.5 ppm) signal intensities, 
which were the apparent APTW signals, showed larger reduc-
tion during the hyperacute stage than the other stages. A trend 
toward higher values of MTRasym(3.5 ppm) signal intensities in 
the ischemic tissue could be observed among the four stages after 
stroke (Figure 2E). On the contrary, MTRasym(3.5 ppm) values in 
the CNWM stayed stable (Figure 2F).
FigUre 3 | aPT and conventional Mr images for different stage patients. (a) F/50 years, a hyperacute stage patient at 2 h after symptom onset. 
APTWave = −0.83%, APTWmax–min = 1.30%. (b) M/54 years, an acute stage patient at 17 h after symptom onset. APTWave = −0.63%, APTWmax–min = 0.99%. (c) 
F/62 years, an early subacute stage patient at 72 h after symptom onset. APTWave = −0.40%, APTWmax–min = 0.72%. (D) M/54 years, a late subacute stage patient 
at 120 h after symptom onset. APTWave = 0.03%, APTWmax–min = 0.53%. Note the presence of CSF artifacts (black thin arrows).
5
Song et al. APTW MRI of Cerebral Ischemia
Frontiers in Neurology | www.frontiersin.org March 2017 | Volume 8 | Article 67
Figure  3 shows the APTW and standard MR images of 
patients at four different stages. From the images, we can see that 
APTW signal intensities in the ischemic tissue were visibly lower 
than the CNWM at the hyperacute stage, the acute stage, and 
the early subacute stage. However, APTW images acquired from 
patients at the late subacute stage showed that the reduction of 
APTW values in the ischemic tissue was not obvious compared 
with those in CNWM (APTW@CNWM), which suggested pH 
restoration might occur.
Quantitative analyses of aPTW and MTr 
signal intensities
Tables 2 and 3 quantitatively compare several APTW and MTR 
parameters at different stages post-stroke. APTWave, APTWmin, 
and APTWmax values were significantly lower in the ischemic 
tissue than APTW@CNWM (P  <  0.05 in all four stages), 
which suggested a reduction of APT effect compared with the 
CNWM occurred after ischemia. APTWave and APTWmax values 
showed no significant differences among different stages, which 
suggested that persistent acidification might exist in the four 
different stages. In addition, APTWmin values in the hyperacute 
stage were significantly lower than the early and late subacute 
stage (P = 0.006, and P = 0.003, respectively), suggesting tissue 
acidification in the ischemic tissue might be more severe in the 
hyperacute stage.
APTWmax–min was significantly higher in patients at the hypera-
cute stage after stroke than in patients at the other three stage 
(P = 0.006, P = 0.001, and P = 0.001, respectively), suggesting 
that the most heterogeneous APTW signal variety existed at the 
hyperacute stage of stroke. In contrast, APTW@CNWM values 
among groups showed no significant difference.
Table 2 | amide proton transfer-weighted (aPTW) intensity values 
among four stages (%; mean value ± se).
Variable hyperacute 
stage
acute stage early 
subacute 
stage
late 
subacute 
stage
APTWave −0.85 ± 0.02 −0.64 ± 0.09 −0.48 ± 0.11 −0.34 ± 0.10
APTWmax −0.02 ± 0.04 −0.24 ± 0.07 −0.23 ± 0.10 −0.11 ± 0.07
APTWmin −1.24 ± 0.04 −1.06 ± 0.10 −0.85 ± 0.08 −0.70 ± 0.09
APTWmax–min 1.22 ± 0.06 0.82 ± 0.07 0.62 ± 0.05 0.59 ± 0.07
APTW@
CNWM
0.15 ± 0.01 0.14 ± 0.01 0.14 ± 0.02 0.16 ± 0.01
t-Test P 
valuesa
<0.001, 0.014, 
<0.001
<0.001, 
<0.001, 
<0.001
0.001, 0.019, 
<0.001
0.008, 0.030, 
<0.001
aThree post hoc P values corresponded to those between APTWave (or APTWmax or 
APTWmin) and APTW@CNWM. Bold indicates a significant change.
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Paired Student’s t-test results showed that the MTR(15.6 ppm) 
value in the ischemic tissue was significantly lower compared with 
that in CNWM at the four stages (P = 0.031, P < 0.001, P < 0.001, 
and P = 0.036, respectively), indicating that the conventional MT 
effect may be reduced after ischemia. In addition, multiple com-
parisons of MTR(15.6 ppm) values in the ischemic tissue among 
groups showed no significant differences, and similar results were 
found for MTR(15.6 ppm) values in the CNWM.
regression analysis of aPTW signal 
intensities with Time
Figure 4 shows the results of regression analysis of APTW sig-
nals against the onset time. There were significantly increasing 
logarithmic time-related changes of the APTWave and APTWmin 
values (R2 = 0.11, P = 0.040; R2 = 0.13, P = 0.022, respectively), 
which indicated that tissue acidification alleviated with time, but 
the goodness-of-fit was relatively poor. In addition, APTWmax–min 
values followed a decreasing logarithmic curve with the onset 
time (R2 = 0.44, P < 0.001), indicating that the APTW signal het-
erogeneity in the ischemic tissue reduced with time, and the most 
significant changes seemingly occurred within the first few hours. 
In contrast, no significant time-related change was observed for 
APTWmax and APTW@CNWM values.
DiscUssiOn
In this study, we used the APTW MRI technique to investigate 
the dynamic change of pH in ischemic tissue in patients at the 
early stage after stroke (the onset to scan time varied from 2 h to 
7 days), which has not been the focus clinically before. We found 
that tissue acidification in the ischemic zone would occur after 
stroke compared with the contralateral normal tissue, and the 
acidification would alleviate with the onset time increased. The 
APTW intensity showed higher heterogeneity at the hyperacute 
and acute stage after stroke, which suggested that pH variety 
existed during this time period. This was consistent with the find-
ing of graded ischemic acidosis in previous studies (24, 25). The 
APTW intensity became more homogeneous as the onset to scan 
time increased. As APTW signals might be affected by potential 
confounding influences of treatment effects, we acquired APTW 
images in patients without receiving interventions of intravenous 
t-PA therapy and endovascular treatment, which would help us 
to describe the dynamic change of APT effect in the progress of 
stroke without treatment interventions.
We studied several APT parameters (APTWave, APTWmax, 
APTWmin, APTWmax–min, and the CNWM APTW signal intensi-
ties) in patients at different stages after stroke and evaluated 
time-related changes of the APTW effect by regression analysis. 
The results showed that APTWave and APTWmin signal intensities 
acquired in the infarction lesions were reduced significantly in 
the ischemic tissue compared with those in the CNWM at the 
hyperacute and acute stages, suggesting that tissue acidosis 
occurred after stroke onset, which had been confirmed by previ-
ous studies during the initial ischemic period of stroke (17, 37). 
The reduction of intracellular pH is mainly due to the accumula-
tion of lactic acid in anaerobic glycolysis, and the correlation of 
APT effect with intracellular pH has been proved (22, 26). In 
addition, APTWave and APTWmin values were also lower com-
pared with those in the CNWM at the subacute stage, which may 
suggest that APTW effect could still be reduced during this time 
period, and the results are consistent with Zhao’s study (38). In 
their study, they just found hypointense APTW signals in a small 
number of stroke patients. As tissue acidification is one of the 
important pathophysiology factors affecting APTW signals (26), 
the reduction of APTWave and APTWmin signals during this stage 
may be partially due to tissue acidification. The results suggested 
that persistent tissue acidification might occur after stroke.
Moreover, we found that APTWave and APTWmin values were 
lower at the hyperacute stage, and higher at the subacute stage 
than the other stages, and the regression analysis demonstrated 
that APTWave and APTWmin signals intensities increased with 
the onset to scan time. The increase of APTWave and APTWmin 
suggested that acidosis of the infarction tissue may be reduced 
and alleviated with the onset to scan time, and this is consistent 
with several previous studies (13, 14), which have showed that the 
reduced pH of ischemic brain would increase after stroke in the 
follow-up of several patients by the MRS method. Similar results 
have been detected in animal models by the APTW MRI method 
(26). The increase of pH after stroke could be explained by active 
Table 3 | MTr(15.6 ppm) intensity values in the ischemic lesion and the contralateral normal white matter (cnWM) among four stages (%; mean 
value ± se).
Variable hyperacute stage acute stage early subacute stage late subacute stage analysis of variance P value
Lesion 26.61 ± 0.89 26.30 ± 0.99 25.39 ± 1.08 23.63 ± 2.58 0.625
CNWM 31.14 ± 1.15 31.08 ± 0.77 30.91 ± 1.92 29.36 ± 1.89 0.840
t-Test P valuesa 0.031 <0.001 <0.001 0.036
at-Test P values corresponded to the results between MTR(15.6 ppm) values in the ischemic lesion and the CNWM. Bold indicates a significant change.
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compensatory mechanisms within the ischemic tissue according 
to prior results (14). In addition, a shift from acute acidosis to 
subacute alkalosis was detected in several works (13, 14, 39, 40), 
and alkalotic pH occurred in the first few days after ischemia 
could be influenced by the duration and degree of ischemia aci-
dosis (41). We did not consistently observe the shift in our current 
data; the deviation of the pH changes might be contributed to the 
confounding factors that may influence the APT imaging results 
in ischemic tissue, such as the tissue temperature (26) and protein 
concentration (17).
Previous studies have shown that the infarct core suffered 
severe acidosis, and the peri-infarct tissue suffered from mod-
erate acidification (25, 42). The heterogeneity of the APTW 
signal (APTWmax–min) may reveal the diversity of pH values in the 
ischemic tissue. From the fitted curve, it showed that APTWmax–
min decreased significantly with the onset to scan time of stroke 
symptoms. The dynamic change of APTWmax–min suggests that 
the ischemic tissue seems to become more homogeneous with 
the increase of onset to scan time. The seemingly significant 
changes occurred during the first few hours after stroke, which 
corresponded to the hyperacute stage, and patients at this stage 
had significantly higher APTWmax–min values than other stages. 
This period is consistent with the therapeutic time window for 
stroke. APTWmax–min may serve as a useful biomarker to reflect 
tissue microenvironment at different time points after ischemia 
and allow further options of stroke interventions.
In addition, APTW signals of the CNWM were stable in the 
four stages, which suggested relatively unremarkable interindi-
vidual variability of the APTW@CNWM values among different 
individuals. The magnetization transfer effect in the ischemic tis-
sue reduced comparing with the CNWM, which may contribute 
to the cerebral edema and partial neuronal death after ischemia. 
Consistent with previous studies, our results for the magnetiza-
tion transfer effect remained stable in the first several days after 
stroke (43, 44). The inconsistency between APTW and MTR 
values in the ischemic tissue suggests APT effect may change 
gradually without the influence of underlying MT effects at the 
early stage after stroke.
Our research shows some preliminary results of pH-weighted 
APT effect in ischemia, which may be helpful for further APTW 
MRI studies in stroke. Here, we mainly focus on patients without 
the consideration of therapeutic interventions, and further stud-
ies are needed to clarify the detailed APT effect changes after 
receiving treatment. Furthermore, due to a very limited number 
of patients receiving PWI in our study, we did not take PWI into 
consideration, which limited the full evaluation of penumbra. 
The number of subjects in our study was relatively small espe-
cially at the hyperacute phase, and patients just received one scan 
without longitudinal follow-up APTW MRI data. Thus, a large-
scale longitudinal study including more patients and scan time 
points would be required to validate our results. In addition, we 
used single slice image acquisition, and APTW signals in other 
ischemic lesions could not be evaluated. Therefore, the three-
dimensional APT imaging method, which has been developed in 
gliomas (45), should be optimized and validated in future stroke 
studies.
Finally, the standard APTW metric, MTRasym(3.5 ppm), was 
used in this study. As reported previously (35, 36), all MTRasym 
spectra were negative at the higher offsets (>3  ppm for the 
ischemic areas or >3.5 ppm for the CNWM) due to the possible 
inherent asymmetry of the conventional MT effect and the pos-
sible NOEs of aliphatic protons of mobile macromolecules (33, 
34). It has been demonstrated recently that MTRasym(3.5  ppm) 
remains a valid metric for APT imaging at 3 T (46, 47). However, 
it is essentially important to obtain relatively pure APT and NOE 
signals and to assess whether both are pH dependent (48–50). In 
this regard, a novel APT imaging analysis approach (46, 47), such 
as the extrapolated semisolid magnetization transfer reference, 
may be used.
In conclusion, our study shows that tissue acidification after 
stroke may alleviate as the onset to scan time increases. APTW 
signal intensities could reflect pH-weighted properties in ischemic 
tissue at different stages and time points. APTW MRI provides an 
alternative method to depict pH changes in ischemia, and APTW 
signals could potentially serve as a surrogate pH-weighted imag-
ing marker in non-invasive and dynamic evaluation of tissue 
evolution in patients at the early stage after stroke.
eThics sTaTeMenT
This study was carried out in accordance with the recommenda-
tions of the human ethics committee of the Beijing Hospital with 
FigUre 4 | experimental and fitted time-related changes of different amide proton transfer-weighted (aPTW) values in the ischemic tissue.  
(a) APTWave values (R2 = 0.11, P = 0.040); (b) APTWmin values (R2 = 0.13, P = 0.022); (c) APTWmax–min values (R2 = 0.44, P < 0.001).
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